These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult]. Kubo T, Takigawa N, Tanimoto Y, Ichihara E, Tabata M, Miyahara N, Kanehiro A, Kiura K, Tanimoto M. Nihon Kokyuki Gakkai Zasshi; 2007 Oct; 45(10):808-11. PubMed ID: 18018632 [Abstract] [Full Text] [Related]
3. Atypical bacterial pathogens in community-acquired pneumonia in children: a hospital-based study. Agarwal J, Awasthi S, Rajput A, Tiwari M, Jain A. Trop Doct; 2009 Apr; 39(2):109-11. PubMed ID: 19299299 [Abstract] [Full Text] [Related]
5. [Mycoplasma pneumoniae and Chlamydophila pneumoniae coinfection in severe pneumoniae among a hospitalized child with respiratory distress: what are the best diagnostic tools for an optimal care?]. Petitjean-Lecherbonnier J, Dina J, Gouarin S, Kozisek S, Poveda JD, Vabret A. Pathol Biol (Paris); 2010 Dec; 58(6):434-6. PubMed ID: 19375247 [Abstract] [Full Text] [Related]
6. [Determination of serologic markers against bacterial atypical pneumonia agents in pneumonia patients]. Pinar A, Ercis S, Ulukavak T, Dursun B, Hasçelik G. Mikrobiyol Bul; 2004 Dec; 38(1-2):27-32. PubMed ID: 15293899 [Abstract] [Full Text] [Related]
17. [Contemporary risks of infections by Mycoplasma pneumoniae and Chlamydophila pneumoniae]. Grabowska-Krawiec P. Pol Merkur Lekarski; 2012 Nov; 33(197):270-3. PubMed ID: 23394038 [Abstract] [Full Text] [Related]
18. Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan. Izumikawa K, Watanabe A, Miyashita N, Ishida T, Hosono H, Kushimoto S, Kohno S. J Infect Chemother; 2014 Sep; 20(9):541-8. PubMed ID: 24934886 [Abstract] [Full Text] [Related]
19. The role of atypical pathogens in community-acquired pneumonia. Gupta SK, Sarosi GA. Med Clin North Am; 2001 Nov; 85(6):1349-65, vii. PubMed ID: 11680106 [Abstract] [Full Text] [Related]
20. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Bartlett JG. Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S232-6. PubMed ID: 18986295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]